Literature DB >> 7563308

Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience.

T W Jarrett1, P M Sweetser, G H Weiss, A D Smith.   

Abstract

PURPOSE: We establish the effectiveness of percutaneous resection of transitional cell carcinomas of the renal collecting system.
MATERIALS AND METHODS: A retrospective analysis was done of 36 kidneys treated during a 9-year period. Adjunctive therapy with bacillus Calmette-Guerin was given in 19 cases.
RESULTS: Of 36 kidneys 6 were treated by immediate nephroureterectomy for aggressive disease, leaving 30 units treated by a complete course. The recurrence rate was 33%, which varied with histology as specific recurrence rates for grades 1 to 3 tumors (18%, 33% and 50%, respectively). The only cancer related mortalities occurred with grade 3 tumors. These tumors also had a higher incidence of understanding and vascular complications. Bacillus Calmette-Guerin therapy showed no significant improvement in survival.
CONCLUSIONS: With vigilant followup, percutaneous management of transitional cell carcinoma of the renal collecting system is an acceptable alternative to nephroureterectomy in patients with grade 1 disease, grade 2 disease who are at risk for renal insufficiency and medical contraindications to a major open operation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7563308

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  21 in total

1.  Ureteroscopic management of upper urinary tract urothelial malignancies.

Authors:  M Grasso
Journal:  Rev Urol       Date:  2000

2.  Canadian guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma.

Authors:  Anil Kapoor; Christopher B Allard; Peter Black; Wassim Kassouf; Christopher Morash; Ricardo Rendon
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

Review 3.  Intracavitary immunotherapy and chemotherapy for upper urinary tract cancer: current evidence.

Authors:  Luca Carmignani; Roberto Bianchi; Gabriele Cozzi; Angelica Grasso; Nicola Macchione; Carlo Marenghi; Sara Melegari; Marco Rosso; Elena Tondelli; Augusto Maggioni
Journal:  Rev Urol       Date:  2013

Review 4.  [Instillation therapies for urothelial carcinoma of the upper urinary tract].

Authors:  P Bosshard; G N Thalmann; B Roth
Journal:  Urologe A       Date:  2019-01       Impact factor: 0.639

Review 5.  Nephron-sparing Management of Upper Tract Urothelial Carcinoma.

Authors:  Francesca Suriano; Tommaso Brancato
Journal:  Rev Urol       Date:  2014

Review 6.  [Endosopic organ-sparing treatment of urothelial tumors of the upper urinary tract: indications and results].

Authors:  M Hruza; C Stock; D Teber; J J Rassweiler
Journal:  Urologe A       Date:  2008-07       Impact factor: 0.639

7.  Endoscopic management of upper tract transitional cell carcinoma.

Authors:  James A Forster; Victor Palit; Anthony J Browning; Chandra Shekhar Biyani
Journal:  Indian J Urol       Date:  2010-04

8.  Comprehensive management of upper tract urothelial carcinoma.

Authors:  Georgios Koukourakis; Georgios Zacharias; Michael Koukourakis; Kiriaki Pistevou-Gobaki; Christos Papaloukas; Athanasios Kostakopoulos; Vassilios Kouloulias
Journal:  Adv Urol       Date:  2008-12-10

9.  Endourologic management of upper tract transitional cell carcinoma following cystectomy and urinary diversion.

Authors:  Jeffrey John Tomaszewski; Marc Christopher Smaldone; Michael Cecil Ost
Journal:  Adv Urol       Date:  2008-12-28

10.  Conservative management of upper tract transitional cell carcinoma.

Authors:  Markian R Iwaszko; Amy E Krambeck
Journal:  Indian J Urol       Date:  2008-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.